Vinícius Augusto Simão1, León Ferder2, Walter Manucha3,4, Luiz Gustavo A Chuffa5. 1. Department of Structural and Functional Biology, Institute of Biosciences, UNESP - São Paulo State University, Zip Code: 510, P.O Box: 18618-689, Botucatu, São Paulo, Brazil. 2. Universidad Maimónides, Ciudad Autónoma de Buenos Aires, Argentina. 3. Laboratorio de Farmacología Experimental Básica Y Traslacional. Área de Farmacología, Departamento de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina. 4. Instituto de Medicina Y Biología Experimental de Cuyo, Consejo Nacional de Investigación Científica Y Tecnológica (IMBECU-CONICET), Mendoza, Argentina. 5. Department of Structural and Functional Biology, Institute of Biosciences, UNESP - São Paulo State University, Zip Code: 510, P.O Box: 18618-689, Botucatu, São Paulo, Brazil. luiz-gustavo.chuffa@unesp.br.
Abstract
PURPOSE OF REVIEW: This review summarizes the involvement of inflammaging in vascular damage with focus on the epigenetic mechanisms by which inflammaging-induced hypertension is triggered. RECENT FINDINGS: Inflammaging in hypertension is a complex condition associated with the production of inflammatory mediators by the immune cells, enhancement of oxidative stress, and tissue remodeling in vascular smooth muscle cells and endothelial cells. Cellular processes are numerous, including inflammasome assembly and cell senescence which may involve mitochondrial dysfunction, autophagy, DNA damage response, dysbiosis, and many others. More recently, a series of noncoding RNAs, mainly microRNAs, have been described as possessing epigenetic actions on the regulation of inflammasome-related hypertension, emerging as a promising therapeutic strategy. Although there are a variety of pharmacological agents that effectively regulate inflammaging-related hypertension, a deeper understanding of the epigenetic events behind the control of vessel deterioration is needed for the treatment or even to prevent the disease onset.
PURPOSE OF REVIEW: This review summarizes the involvement of inflammaging in vascular damage with focus on the epigenetic mechanisms by which inflammaging-induced hypertension is triggered. RECENT FINDINGS: Inflammaging in hypertension is a complex condition associated with the production of inflammatory mediators by the immune cells, enhancement of oxidative stress, and tissue remodeling in vascular smooth muscle cells and endothelial cells. Cellular processes are numerous, including inflammasome assembly and cell senescence which may involve mitochondrial dysfunction, autophagy, DNA damage response, dysbiosis, and many others. More recently, a series of noncoding RNAs, mainly microRNAs, have been described as possessing epigenetic actions on the regulation of inflammasome-related hypertension, emerging as a promising therapeutic strategy. Although there are a variety of pharmacological agents that effectively regulate inflammaging-related hypertension, a deeper understanding of the epigenetic events behind the control of vessel deterioration is needed for the treatment or even to prevent the disease onset.
Authors: Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais Journal: Eur Heart J Date: 2018-09-01 Impact factor: 29.983
Authors: Antonio Cannatà; Luca Camparini; Gianfranco Sinagra; Mauro Giacca; Francesco S Loffredo Journal: Cardiovasc Res Date: 2016-07-01 Impact factor: 10.787
Authors: Alberto Maria Marra; Eduardo Bossone; Andrea Salzano; Roberta D'Assante; Federica Monaco; Francesco Ferrara; Michele Arcopinto; Olga Vriz; Toru Suzuki; Antonio Cittadini Journal: Heart Fail Clin Date: 2018-07 Impact factor: 3.179